Numerous reports demonstrate the prognostic and therapeutic value of OCT1 transcriptional targets across diverse malignancies including breast cancer, lung cancer, colorectal cancers and so on [15, 16]. The gene discussed is POU2F1; the disease is breast carcinoma.